Clinical Trial Update: Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study in healthy participants comparing two formulations of BMS-986177.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombosis

Drugs mentioned

• BMS-986177

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Thrombosis | Phase 1 | Status: COMPLETED